Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Glaxosmithkline Plc (NY: GSK )

34.91 USD +0.63 (+1.84%)
Official Closing Price Updated: 7:53 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Glaxosmithkline Plc

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
New GSK chairman backs CEO Witty to stay at helm
LONDON, May 7 (Reuters) - GlaxoSmithKline's new chairman Philip Hampton expressed support for the company's current structure and its chief executive on Thursday while speaking to reporters after the... 
Tags companyNews
From Reuters: Company News
RPT-Under pressure, FDA to hold public meeting on off-label use
WASHINGTON, May 7 (Reuters) - The U.S. Food and Drug Administration will hold a public meeting this summer to address drug company concern that restrictions on what they can say about off-label use of... 
Tags companyNews
From Reuters: Company News
Under pressure, FDA to hold public meeting on off-label use
WASHINGTON, May 6 (Reuters) - The U.S. Food and Drug Administration will hold a public meeting this summer to address drug company concern that restrictions on what they can say about off-label use of... 
Tags companyNews
From Reuters: Company News
PRESS DIGEST- British Business - May 7
May 7 - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. 
Tags companyNews
From Reuters: Company News
GSK sees little prospect of U.S. generic Advair in 2016
LONDON, May 6 (Reuters) - After relying for years on its top-selling lung drug Advair, GlaxoSmithKline is now braced for the worst in the form of cheap generics - but not just yet. 
Tags companyNews
From Reuters: Company News
SodaStream International Ltd, GlaxoSmithKline Plc Report Earnings
SodaStream and GlaxoSmithKline released the earnings results from their first fiscal quarters before opening bell this morning. 
Tags Consumer Goods Healthcare Stocks / Equities
From Blogs - TalkMarkets
UPDATE 2-GSK scraps plan to list HIV drugs business and shields dividend
* Q1 revenue 5.62 billion pounds, in line with consensus (Adds reaction and context) 
Tags companyNews
From Reuters: Company News
US stocks open higher as Street eyes yields, oil
U.S. stocks opened higher, recovering from the prior day's losses, as higher yields and energy prices remained in focus ahead of Friday's jobs data. 
Tags 21st Century Fox A Economics/Economy Whole Foods Market Inc
From CNBC.com News
BRIEF-GlaxoSmithKline CEO comments from media roundtable
* Ceo says ~has different view from other companies on further drug pricing pressures 
Tags companyNews
From Reuters: Company News
Early movers: GEVA, MGI, JPM, WEN, NWSA & more
These are the stocks posting the largest moves before the bell. 
Tags Moneygram International Inc/ Investing/Wall Street Papa Johns International Inc
From CNBC.com News
GSK rules out HIV spinout as generics hit results
GlaxoSmithKline looks set to continue its earnings slide in 2015, as generic competition continues to hit sales of asthma treatment Advair. 
Tags Novartis AG GlaxoSmithKline PLC Business/Earnings
From CNBC.com News
Wall Street eyes rebound amid data and spiking yields
U.S. stock index futures pointed to a firm open for Wall Street shares Wednesday, following the previous day's sharp falls and ahead of some key data releases as Treasury yields rose. 
Tags Nasdaq Investing/Currencies/U/S/ Dollar Economics
From CNBC.com News
Higher yields sting stocks as jobs take center stage
Payroll data will be key for bonds, stocks and the dollar, and it could set the stage for a bigger markets move when jobs report number is released. 
Tags GlaxoSmithKline PLC Anheuser/Busch Inbev SA Whole Foods Market Inc
From CNBC.com News
Europe seen higher, earning in focus
European equities are expected to open higher Wednesday as investors await a slew of earnings reports. 
Tags Societe Generale Anheuser/Busch Inbev SA Credit Agricole SA
From CNBC.com News
Higher rates sting stocks; markets await job data
Payroll data will be key for bonds, stocks and the dollar, and it could set the stage for a bigger markets move when jobs report number is released. 
Tags GlaxoSmithKline PLC Anheuser/Busch Inbev SA Whole Foods Market Inc
From CNBC.com News
Siemens, regulator deny China bribery report
SHANGHAI, May 5 (Reuters) - Siemens AG and China's State Administration for Industry and Commerce (SAIC), a competition regulator, denied a Reuters report that the SAIC investigated the German group's... 
Tags companyNews
From Reuters: Company News
US stocks open lower; data in focus
U.S. stocks opened lower on Tuesday as investors eyed a decline in equity markets overseas and awaited fresh domestic data for April. 
Tags Economics Investing/Currencies/U/S/ Dollar /DXY
From CNBC.com News
US stocks open higher; Fed speakers, data eyed
U.S. stocks opened higher on Monday, following positive momentum from Europe, as investors looked ahead to a week of Federal Reserve speeches and economic data that could shed light on the timing of an... 
Tags Sysco Corp Economics Investing/Currencies/U/S/ Dollar
From CNBC.com News
Jobs report is big but watch out for Europe
Influences from abroad may first drive stocks, bonds and the dollar. 
Tags LendingClub Corp Groupon Herbalife LTD/
From CNBC.com News
Jobs report is big but watch out for Europe
Influences from abroad may first drive stocks, bonds and the dollar. 
Tags TRW Automotive Holdings Corporation Sysco Corp Zynga
From CNBC.com News
CORRECTED-U.S. FDA approves Glaxo, Theravance's Breo Ellipta asthma drug
April 30 (Reuters) - The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and... 
Tags companyNews
From Reuters: Company News
Doubts grow over GlaxoSmithKline's $6 bln capital return plan
LONDON, May 1 (Reuters) - GlaxoSmithKline may ditch a plan to return 4 billion pounds ($6.1 billion) to investors, some analysts believe, as the drugmaker prepares to set out its vision for the... 
Tags companyNews
From Reuters: Company News
U.S. FDA approves Glaxo, Theravance's Breo Ellipta asthma drug
April 30 (Reuters) - The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and... 
Tags companyNews
From Reuters: Company News
UPDATE 1-Nexium, Advair led Medicare drug spending in 2013 -officials
NEW YORK, April 30 (Reuters) - Four brand-name medications accounted for almost one-tenth of the $103 billion in prescriptions filled by older or disabled Americans under Medicare's drug program in... 
Tags companyNews
From Reuters: Company News
Nexium, Advair led Medicare drug spending in 2013 - officials
NEW YORK, April 30 (Reuters) - Four brand-named drugs prescribed to older or disabled Americans covered by Medicare's drug benefit accounted for almost one-tenth of the $103 billion in prescriptions... 
Tags companyNews
From Reuters: Company News
Big Upcoming Catalysts For These 2 Small Biotechs
Protalix has a market capitalization of around $200 million, one fast growing approved product, and four other compounds in early development and the shares seem worthy of a small, speculative... 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
GSK shingles vaccine shows benefits across all age groups
LONDON, April 28 (Reuters) - An experimental shingles vaccine from GlaxoSmithKline is effective across all age groups, researchers said on Tuesday, boosting the prospects of a key product in the... 
Tags companyNews
From Reuters: Company News
GSK readies "bubble boy" drug as big pharma bets on gene therapy
LONDON, April 27 (Reuters) - GlaxoSmithKline is close to seeking European approval for a gene therapy drug to fight the immune deficiency disorder known as "bubble boy" disease, in the latest sign of a... 
Tags companyNews
From Reuters: Company News
Earnings lift markets to higher close
Upbeat earnings lifted the markets to a higher close with Dow gaining 21 points to 18,080. Nasdaq climbed 36 points to 5,092. 
Tags Market News
From MarketMinute.com Market Updates
Earnings lift markets to higher close
Tags AGEN MSFT DV
From MarketMinute » Market Updates
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.